Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Clinical research sponsor

Published trials6

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

6 shown

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced ConstipationNCT01901341 · lead sponsor · 2013-07-02

TERMINATED

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced ConstipationNCT01901302 · lead sponsor · 2013-05-20

TERMINATED

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced ConstipationNCT01901328 · lead sponsor · 2013-04-07

TERMINATED

Safety Study of CB-5945 for the Treatment of Opioid-Induced ConstipationNCT01696643 · lead sponsor · 2012-10-12

TERMINATED

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid ArthritisNCT00626275 · lead sponsor · 2007-10-01

COMPLETED

Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based RegimensNCT01133600 · collaborator · 2010-08-01

TERMINATED

Sponsor roles

lead sponsor5

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.